Literature DB >> 25431071

Stem cells, neural progenitors, and engineered stem cells.

Raj R Rao1, Shilpa Iyer.   

Abstract

Human pluripotent stem cells (hPSCs ) have the unique potential to form every cell type in the body. This potential provides opportunities for generating human progenitors and other differentiated cell types for understanding human development and for use in cell type-specific therapies. Equally important is the ability to engineer stem cells and their derived progenitors to mimic specific disease models. This chapter will focus on the propagation and characterization of human neural progenitors (hNPs ) derived from hPSCs with a particular focus on engineering hNPs to generate in vitro disease models for human neuro-mitochondrial disorders. We will discuss the methodologies for culturing and characterizing hPSCs and hNPs; and protocols for engineering hNPs by using a novel mitochondrial transfection technology.

Entities:  

Mesh:

Year:  2015        PMID: 25431071      PMCID: PMC5642280          DOI: 10.1007/978-1-4939-2152-2_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

Review 1.  Stem cell-based models and therapies for neurodegenerative diseases.

Authors:  Shilpa Iyer; Khaled Alsayegh; Sheena Abraham; Raj R Rao
Journal:  Crit Rev Biomed Eng       Date:  2009

2.  Human motor neuron differentiation from human embryonic stem cells.

Authors:  Soojung Shin; Stephen Dalton; Steven L Stice
Journal:  Stem Cells Dev       Date:  2005-06       Impact factor: 3.272

3.  Mitochondrial gene therapy improves respiration, biogenesis, and transcription in G11778A Leber's hereditary optic neuropathy and T8993G Leigh's syndrome cells.

Authors:  Shilpa Iyer; Kristen Bergquist; Kisha Young; Erich Gnaiger; Raj R Rao; James P Bennett
Journal:  Hum Gene Ther       Date:  2012-04-17       Impact factor: 5.695

4.  Mitochondrial gene replacement in human pluripotent stem cell-derived neural progenitors.

Authors:  S Iyer; E Xiao; K Alsayegh; N Eroshenko; M J Riggs; J P Bennett; R R Rao
Journal:  Gene Ther       Date:  2011-09-15       Impact factor: 5.250

5.  An SMA project report: neural cell-based assays derived from human embryonic stem cells.

Authors:  Patricia G Wilson; Jonathan J Cherry; Shelle Schwamberger; Allison M Adams; Jianhua Zhou; Soojung Shin; Steven L Stice
Journal:  Stem Cells Dev       Date:  2007-12       Impact factor: 3.272

6.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

7.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

8.  Human neural progenitor cells derived from embryonic stem cells in feeder-free cultures.

Authors:  Sujoy K Dhara; Kowser Hasneen; David W Machacek; Nolan L Boyd; Raj R Rao; Steven L Stice
Journal:  Differentiation       Date:  2008-01-03       Impact factor: 3.880

9.  Nuclear factor I isoforms regulate gene expression during the differentiation of human neural progenitors to astrocytes.

Authors:  Katarzyna M Wilczynska; Sandeep K Singh; Bret Adams; Lauren Bryan; Raj R Rao; Kristoffer Valerie; Sarah Wright; Irene Griswold-Prenner; Tomasz Kordula
Journal:  Stem Cells       Date:  2009-05       Impact factor: 6.277

10.  Recombinant mitochondrial transcription factor A with N-terminal mitochondrial transduction domain increases respiration and mitochondrial gene expression.

Authors:  Shilpa Iyer; Ravindar R Thomas; Francisco R Portell; Lisa D Dunham; Caitlin K Quigley; James P Bennett
Journal:  Mitochondrion       Date:  2009-02-04       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.